
(AGENPARL) – SILVER SPRING lun 12 giugno 2023 These letters are supplied by the CDER Freedom of Information Office and only covers Office of Prescription Drug Promotion’s untitled letters. The agency may have redacted or edited some of the letters to remove confidential information.
Fonte/Source: http://www.fda.gov/drugs/warning-letters-and-notice-violation-letters-pharmaceutical-companies/untitled-letters-2018